Capital International buys 3% stake in Intas Pharmaceuticals for $107 million

PE firm buys stake from ChrysCapital in a transaction that values Intas Pharmaceuticals at about $3.5 billion

Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.